| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283255A1 Myocardial cell proliferation-associated genes |
| 02/12/2003 | EP1283216A1 Somatostatin analogues binding to all somatostatin receptor subtypes and their use |
| 02/12/2003 | EP1283215A2 Secreted polypeptide and nucleic acids encoding it |
| 02/12/2003 | EP1283214A1 Novel collectins |
| 02/12/2003 | EP1283212A1 Methods for identifying compounds that bind to a target |
| 02/12/2003 | EP1283059A2 Therapeutic conjugates of toxins and drugs |
| 02/12/2003 | EP1282822A2 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen |
| 02/12/2003 | EP1282816A2 Improved assay techniques using nematode worms |
| 02/12/2003 | EP1282727A1 Methods for identifying candidate polynucleotide molecules encoding a protease |
| 02/12/2003 | EP1282721A1 Prion-free transgenic ungulates |
| 02/12/2003 | EP1282718A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/12/2003 | EP1282717A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence |
| 02/12/2003 | EP1282712A2 Synthetic gagpol genes and their uses |
| 02/12/2003 | EP1282711A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF i EHRLICHIA INFECTION /i |
| 02/12/2003 | EP1282710A2 Fish vaccine against piscirickettsia salmonis |
| 02/12/2003 | EP1282708A1 A method for generating hypermutable plants |
| 02/12/2003 | EP1282707A2 Regulation of human p2y-like g protein-coupled receptor |
| 02/12/2003 | EP1282706A2 Natrium-calcium exchanger protein |
| 02/12/2003 | EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 02/12/2003 | EP1282704A2 Cng3b: a novel cyclic nucleotide-gated cation channel |
| 02/12/2003 | EP1282702A2 Immunogenic polypeptides encoded by mage minigenes and uses thereof |
| 02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
| 02/12/2003 | EP1282696A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 02/12/2003 | EP1282692A2 Sentinel virus ii |
| 02/12/2003 | EP1282674A1 Drilling fluids and method of drilling |
| 02/12/2003 | EP1282646A2 Human monoclonal antibodies to dendritic cells |
| 02/12/2003 | EP1282645A2 G protein-coupled receptors |
| 02/12/2003 | EP1282644A1 Tm4sf receptor polynucleotides, polypeptides, and antibodies |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282642A2 Therapeutic pore-forming peptides |
| 02/12/2003 | EP1282641A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
| 02/12/2003 | EP1282640A2 Nucleic acid immunization |
| 02/12/2003 | EP1282638A1 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 02/12/2003 | EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 02/12/2003 | EP1282635A1 Novel nucleic acids and polypeptides |
| 02/12/2003 | EP1282634A1 Atm mutations in breast cancer |
| 02/12/2003 | EP1282441A2 Treating t-cell mediated diseases by modulating dr6 activity |
| 02/12/2003 | EP1282437A2 Method for treating cartilage disorders |
| 02/12/2003 | EP1282434A1 Method for cell adhesion and wound healing |
| 02/12/2003 | EP1282433A1 Transgenically produced decorin |
| 02/12/2003 | EP1282432A1 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 02/12/2003 | EP1282425A1 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
| 02/12/2003 | EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/12/2003 | EP1150942A4 Improved compounds for protein binding |
| 02/12/2003 | EP1094833B1 Oxidized thymosin beta 4 |
| 02/12/2003 | EP0910658A4 Protein expression system |
| 02/12/2003 | EP0871456B1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd |
| 02/12/2003 | EP0728147B1 Receptor specific atrial natriuretic peptides |
| 02/12/2003 | EP0637246B1 Use of modified c-reactive protein for the preparation of a medicament for the treatment of cancer |
| 02/12/2003 | CN1396927A Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 02/12/2003 | CN1396805A Transgenic coat producing milk containing human granulocyte-colony stimulating factor |
| 02/12/2003 | CN1396261A Human growth and differentiation factor 7 and its coding sequence preparing process and application |
| 02/12/2003 | CN1396260A Ox bLATS1 gene, nucleotide, protein coding sequence and its preparing process and application |
| 02/12/2003 | CN1396259A Chicken cLATS1 gene, nucleoside, proteincoding sequence and its preparing process and application |
| 02/12/2003 | CN1396180A Process for preparing cross-linked haematoglobin as substitute of red blood cell |
| 02/12/2003 | CN1396179A Anti fungal polypeptide extracted from eucommia bark and its extracting process |
| 02/12/2003 | CN1396176A Method for purifying drug active protein by cation exchange chromatogrphy |
| 02/12/2003 | CN1101403C Preparation of granulocyte colony stimulation factor |
| 02/12/2003 | CN1101224C Injection for giving up addiction |
| 02/11/2003 | US6518487 Isolated nucleic acid; increases transformation efficiency; use to control cell division and cell cycle regulation |
| 02/11/2003 | US6518484 Promoter system of plant translationally controlled tumor protein gene |
| 02/11/2003 | US6518483 Expression of nucleotide sequence, for gene encoding Knox1, in a plant; can use to increase plant growth and disease resistance; genetic engineering |
| 02/11/2003 | US6518482 Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor |
| 02/11/2003 | US6518481 Universal markers of transgenesis |
| 02/11/2003 | US6518480 Selective target cell activation by expression of a G protein-coupled receptor activated superiorly by synthetic ligand |
| 02/11/2003 | US6518414 Isolated polynucleotide molecule which encodes a polypeptide of given sequence; can be used in diagnosis/treatment of cancer and to produce antibodies |
| 02/11/2003 | US6518413 Isolated nucleic acid encoding the polypeptide which, on expression in a host cell, produces the polypeptide; use in treatment of muscular dystrophy |
| 02/11/2003 | US6518412 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 02/11/2003 | US6518411 Rieger Syndrome; isolated nucleic acid encoding a polypeptide of given sequence; can be used in diagnosis and treatment |
| 02/11/2003 | US6518406 Adding a saccharide and citrate to a solution of antithrombin-III to precipitate the impurities; used in the prophylaxis and treatment of thromboembolic disorders |
| 02/11/2003 | US6518404 Human endothelin-bombesin receptor antibodies |
| 02/11/2003 | US6518403 Antibodies that bind an adipocyte-specific protein homolog |
| 02/11/2003 | US6518402 Antibodies to c5 polypeptides |
| 02/11/2003 | US6518401 Polypeptide for use in the treatment and prevention of tumors and infections |
| 02/11/2003 | US6518400 Polypeptide that affects the organization of chromosomes within the nucleus; heterochromatin |
| 02/11/2003 | US6518399 Isolation of novel GABAb-R2 receptor protein subtype; Gamma-amino-butyric acid (GABA); human neurotransmitter; amino acid and nucleotide sequences |
| 02/11/2003 | US6518398 ERG potassium channel |
| 02/11/2003 | US6518397 Pharmaceuticals for modulating hormone responsiveness |
| 02/11/2003 | US6518256 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/11/2003 | US6518255 Administering, via multiple applications to target tissue, a dose of an adenoviral vector comprising a DNA encoding an angiogenic peptide which is an endothelial growth factor and a carrier to increase level of perfusion of blood to target |
| 02/11/2003 | US6518241 Shock heat treatment of polypeptides |
| 02/11/2003 | US6518237 Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 02/11/2003 | US6518236 FGF homologs |
| 02/11/2003 | US6518235 Methods for improving brain function using leptin or analogs thereof |
| 02/11/2003 | US6518065 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 02/11/2003 | US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor |
| 02/11/2003 | US6518061 Interleukin-13 (IL-13); Delivery of a modified Pseudomonas exotoxin (effector molecule), attached to an interleukin, to tumor cells bearing interleukin receptors; antitumor agent |
| 02/11/2003 | US6518055 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6518045 Feline cytokine protein |
| 02/11/2003 | US6518044 Promoters for expressing genes in a fungal cell |
| 02/11/2003 | US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells |
| 02/11/2003 | US6518042 A filamentous fungal cell, wherein a gene involved in the mismatch repair system has been inactivated and in which the gene involved in the mismatch repair system comprises a DNA sequence encoding the polypeptide sequence shown in positions |
| 02/11/2003 | US6518037 Two-component system that controls bacterial membrane synthesis |
| 02/11/2003 | US6518031 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/11/2003 | US6518030 Non-infectious, retrovirus-like particles comprise an assembly of an env gene product, a pol gene product and a gag gene product contain an antigenic marker which is non-retroviral or non-HIV retroviral. In one embodiment, the |
| 02/11/2003 | US6518028 Methods for the early diagnosis of ovarian and prostate cancer |
| 02/11/2003 | US6518018 RNA-antibody fusions and their selection |
| 02/11/2003 | US6518016 Screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C (APC). The method is directed at detecting one or more mutations at one or more of the cleavage and/or binding |